Table 2.
Characteristics of patients in the group islet-after-failed pancreas transplantation, and patient with failed pancreas transplantation on the waitlist for islet transplantation.
ID # | Gender | Age atthe time of the 1st ITX | Age at the time of the PTX | Type ofPTX | # of ITX | Total IEQ/Kg received | Period of insulin independance after ITX (days) | Cause of PTX failure | Interval PTX to pancreas failure (days) | Interval pancreas failure to ITX (days) | cPRA pre first ITX | HbA1C pre-first ITX (%) | HbA1C at last FU (%) | Insulin requirement pre-first ITX (units/kg/day) | Insulin requirement at last FU (units/kg/day) | Wait time listing for ITX-ITX (days) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IAP-1 | F | 31 | 31 | SPK | 2 | 14,476 | Off insulin | SVT | 4 | 24 | 0 | 7.7 | 5.3 | 0.69 | 0 | 10 |
IAP-2 | M | 52 | 49 | PAK | 2 | 10,831 | 0 | NPanc | 111 | 1014 | 70 | 10.5 | 12.1 | 0.67 | 0.43 | 278 |
IAP-3 | M | 36 | 35 | SPK | 1 | 5,033 | 0 | SVT | 1 | 106 | 0 | 6.4 | 5.0 | 0.62 | 0.67 | 101 |
IAP-4 | F | WL | 41 | SPK | WL | WL | WL | NPanc | 8 | WL | 95 (WL) | 8.6 † | WL | 0.33 † | WL | 10† |
IAP: Islet after Pancreas; PTX: pancreas transplant; ITX: islet transplant; SPK: Simultaneous pancreas/kidney transplant; PAK: Pancreas after kidney transplant; KTX: kidney transplant; IEQ: Islet equivalent; SVT: splenic vein thrombosis; NPanc: Necrotizing pancreatitis; cPRA: calculated Panel Reactive Antibodies; WL: on the waitlist for ITX, not transplanted yet; †: at the time of writing of the manuscript